Introduction {#s0005}
============

The dentition of mice is highly reduced, with only one incisor separated by a diastema region from three molars in each quadrant. The first sign of mammalian tooth development for both type of teeth, molars and incisors, is a thickening of the oral epithelium in the tooth area around embryonic day (E) 11. Molar and incisor developments are in principle similar, but differ slightly in developmental timing and with respect to gene expression. Tooth development requires sequential and reciprocal interactions between the dental epithelium and dental mesenchyme mediated by different signaling pathways ([@bb0020]). The thickened dental epithelium expresses growth factors such as the Fibroblast growth factor 8 (Fgf8) and Sonic hedgehog (Shh). Concurrent with its thickening the proliferating epithelium invaginates into the underlying mesenchyme. The mesenchyme condenses around the invaginated epithelium, resulting in the formation of a dental bud stage around E12.5 (bud stage) in the incisor region. Subsequently, the invaginating epithelium extends farther into the mesenchyme and in response to mesenchymal signals, such as bone morphogenetic protein-4 (BMP4), the enamel knot, a non-proliferating transient epithelial structure, appears at the cap stage (around E13.5 for the incisor). Mesenchymal *Bmp4* expression is regulated by transcription factors such as Msx1 and Pax9 ([@bb0030; @bb0200]). Amongst other molecules the enamel knot expresses *Shh* and *Fgf4* and serves as a signaling center that regulates dental papilla formation in the adjacent mesenchyme and proliferation of the remaining dental epithelium ([@bb0240]). The epithelium extends further by differential proliferation and forms a bell shaped structure enclosing the mesenchyme (bell stage; ≥ E16 for the incisor). During the bell stage, epithelial cells adjacent to the mesenchyme differentiate further into enamel-producing ameloblasts and the mesenchymal cells into dentin-producing odontoblasts.

Previous studies provided evidence for a key role for the Wnt/β-catenin pathway in the dental epithelium during tooth morphogenesis. The pathway is activated by binding of a Wnt-ligand to a receptor complex composed out of a frizzled family member and LDL receptor related protein (Lrp5/6), which leads to the inhibition of a cytoplasmic destruction complex containing the Adenomatosis polyposis coli (APC), Axin and GSK3 kinase proteins. Thus cytosolic β-catenin accumulates and translocates to the nucleus where it assembles into a transcriptional activating complex with members of the Tcf/Lef transcription factor family ([@bb0150]). Loss of *Lef1*, which is expressed in the dental mesenchyme and epithelium causes arrest of tooth development at the bud stage ([@bb0260]) and tissue recombination experiments showed that Lef1 activity is required in the dental epithelium to regulate *Fgf4* expression and cell survival ([@bb0115; @bb0220]). Constitutive activation of the Wnt/β-catenin pathway in the oral epithelium results in the formation of ectopic invaginations, giving rise to ectopic teeth ([@bb0100; @bb0120; @bb0140; @bb0265]). A similar but less severe phenotype is observed when *Lef1* is overexpressed in the oral epithelium ([@bb0275]). Inhibition of the Wnt/β-catenin pathway by overexpression of the secreted inhibitor Dickkopf 1 (Dkk1) in the oral epithelium results in an early arrest of tooth development ([@bb0005; @bb0140]). Genetic deletion of *β-catenin* in the oral epithelium results in a similar albeit less severe phenotype ([@bb0140]). Until recently, most of the published experimental approaches, with the exception of inhibiting the pathway by *Dkk1* overexpression, which may also affect the dental mesenchyme, demonstrated a role for Wnt/β-catenin in the dental epithelium and not in the mesenchyme during tooth development. Direct evidence for a role of the canonical Wnt-pathway in the mesenchyme, was for the first time provided through conditional inactivation of *β-catenin* in the dental mesenchyme, which lead to an arrest of molar development at the cap stage ([@bb0035]).

Here we investigated the requirement for Wnt/β-catenin signaling in the incisor mesenchyme using a conditional approach and showed that locally restricted loss of *β-catenin* from the mandibular incisor region results in the formation of double incisors. Molecular analysis revealed that β-catenin is required in the mesenchyme to positively regulate *Bmp4* expression. This occurs independent of *Msx1* and is directly mediated by the activity of Tcf/Lef transcription factors. Furthermore, we provide *in vitro* and genetic *in vivo* evidence that mesenchymal BMP4 activity is required to maintain *Shh* expression in the overlying dental epithelium. Thus our results show that mesenchymal activity of β-catenin is required for incisor development and indicate that incisor numbers can be altered through local modulation of β-catenin activity.

Materials and methods {#s0010}
=====================

Animals and preparation of embryonic tissues {#s0015}
--------------------------------------------

The transgenic mouse lines for *β-catenin, β-cat*^*fl*^ (conditional allele) and *β-cat*^*lacZ*^ (null allele), *Bmp4*, *Bmp4*^*∆LacZ*^ (null allele), *Bmp4*^*hf*^ (hypomorphic conditional allele) and *Bmp4*^*fl*^ (conditional allele), *Lef1*^−^ (null allele), *Tcf1*^−^ (null allele) and *Prx1-Cre* used in this study have been described earlier and genotyping was performed accordingly ([@bb0010; @bb0025; @bb0065; @bb0085; @bb0090; @bb0155]). Intercrosses to generate the mutants were done as described previously ([@bb0010; @bb0065; @bb0075]). *Bmp4*^*∆Prx1/∆GL*^ mutants were generated taking advantage of the germ line activity of *Prx1-Cre* females through intercrosses of *Prx1-Cre* females with *Bmp4*^*fl/fl*^ males. From the offspring *Bmp4*^*∆GL/+*^*;Prx1Cre* males were crossed with *Bmp4*^*fl/fl*^ females to generate the desired mutants. Embryos were staged according to morphological criteria; plug date was considered to be E0.5. Whole heads or lower jaws were dissected in PBS, fixed in 4% paraformaldehyde, dehydrated with methanol and ethanol for whole mount and paraffin section in situ hybridizations, respectively. All mouse experiments were performed in accordance with local and institutional regulations and licenses.

Cre recombinase and Wnt activity detection {#s0020}
------------------------------------------

For the detection of Cre recombinase *Prx1-Cre* mice were crossed with *Z/AP* mice ([@bb0145]) and stained for alkaline phosphatase ([@bb0075]). For the detection of Wnt activity in E11.5--E13.5 mandibles, heads from *BAT-gal* ([@bb0165]), *TOP-gal* ([@bb0045]) and *Axin2-lacZ* ([@bb0160]) mice were dissected and fixed in 2% paraformaldehyde/0.2% glutaraldehyde in PBS and stained in X-gal solution for 20 h to detect β-galactosidase activity as previously described ([@bb0100]).

Skeletal preparations, in situ hybridizations and immunohistochemistry {#s0025}
----------------------------------------------------------------------

Heads of newborns (P0) embryos were skinned, fixed in 95% ethanol and stained with alizarin red and Alcian blue ([@bb0170]). Whole mount (on dissected mandibles) and section (5 μm paraffin-sections) in situ hybridizations were performed as described ([@bb0195; @bb0215]). Double-color and double fluorescence in situ hybridization on serial paraffin sections were performed using Digoxigenin (DIG) and Fluorescein (Flu) and Biotin and DIG labeled probes, respectively, as described previously ([@bb0015; @bb0250]). All probes used are available upon request. Immunohistochemistry was performed on paraffin sections using anti-β-catenin mAb (BD Transduction Laboratories, 1:200) as described ([@bb0235]). Ki67 (Novocastra, 1:1000) and Caspase-3 (Cell signaling, 1:100) immunohistochemistry was performed using the automated Discovery XT system (Ventana Medical Systems).

Tissue recombination experiments and kidney capsule transplantation {#s0030}
-------------------------------------------------------------------

Incisor anlagen from E12.5 mandible of WT and *β-cat*^*fl/fl*^ mice were dissected in Dulbecco\'s PBS (pH 7.4) under a stereomicroscope. Dental epithelium and mesenchyme were separated after incubation in a 2.25% Trypsin (Sigma)/0.25% Pancreatin (Sigma)/Tyrode\'s solution (pH 7.4) for 2 min at room temperature, followed by incubation in DMEM/10% FCS (Autogen Bioclear) to stop Protease digestion. Given that it has been shown that excessive removal of dental mesenchyme can affect incisor number ([@bb0180]), we took care not to remove any dental mesenchyme. Separated *β-cat*^*fl/fl*^ mesenchyme was inoculated with 1 × 10^10^ pfu/ml Adeno-GFP or Adeno-Cre each (Gene transfer vector core, University of Iowa) in DMEM/10% FCS for 1 h at 37 °C in 5% CO~2~. *β-cat*^*fl/fl*^ adenovirus-infected mesenchyme recombined with uninfected wild-type epithelium in the right orientation on Nuclepore filters, and cultured on metal grids at 37 °C in 5% CO~2~. After 1 day in culture, the recombined samples were transplanted under the kidney capsule of anesthetized immuno-compromised mice. The cut was sutured and after 3 weeks the mouse was killed, and the kidneys were carefully removed.

Bead implantations {#s0035}
------------------

Implantation of NOGGIN and BSA coated beads were performed by following published protocol ([@bb0255]). Affi-Gel blue agarose beads (Bio Rad) were incubated in 100 ng/μl recombinant mouse Noggin (R&D) for 45 min at 37 °C. Heparin acrylic beads (Sigma) incubated for 45 min at 37 °C in PBS containing 0.1% BSA were used as controls. Control beads were implanted near the presumptive incisor regions in the left quadrant and NOGGIN beads in the right quadrant of dissected mandibular explants from WT E11.5 embryos. Explants were then placed on Nuclepore filters and cultured supported by metal grids in DMEM / 10% FCS. After 48 h the explants were fixed in 100% methanol for 5 min followed by an overnight fixation in 4% paraformaldehyde, and processed for whole-mount in situ hybridization.

Real-time PCR {#s0040}
-------------

For real-time PCR analysis, DNase I-treated total RNA (1 μg) was reverse transcribed using oligo (dT) to produce first-strand cDNA. Real-time PCR was performed using SYBR greenI nucleic acid gel stain (Roche) and TAKARA rTaq. Values were calculated using the relative standard method and normalized to mouse *Hprt1* expression. Primers sets were tested by dilution series and products were analyzed by gel electrophoresis and melting curves. cDNA were amplified using the following primer pairs:*Bmp4:* sense, CGTTACCTCAAGGGAGTGGA and anti-sense ATGCTTGGGACTACGTTTGG;*Bmp7*: sense, TACGTCAGCTTCCGAGACCT and anti-sense, GGTGGCGTTCATGTAGGAGT;*Hprt1*: sense, AGCTACTGTAATGATCAGTCAACG, and anti-sense, AGAGGTCCTTTTCACCAGCA.

Luciferase promoter studies {#s0045}
---------------------------

The mouse *Bmp4* reporter plasmids were constructed by cloning the −3000/+120 fragment (3 kb) and the −4820/+120 fragment (4.8 kb) of the mouse *Bmp4* genomic region into the pGL3-Basic luciferase vector (Promega). HEK293T cells (8 × 10^5^ cells/well) were co-transfected with each reporter plasmid (0.5 μg) and a total of 2 μg DNA containing the respective concentrations of expression plasmids (kindly provided by H. Clevers) and pcDNA3.1 (Invitrogen) together with 0.05 μg of Renilla luciferase reporter plasmid pRL-CMV (Promega) using calcium phosphatase co-precipitation procedure. 24 h after transfection, firefly and Renilla luciferase activities were measured using the Dual-Glo luciferase assay system (Promega) following the manufacturer\'s protocol on a Synergy 2 Multi-Detection Microplate Reader (BioTek Instruments). Firefly activity was standardized against the Renilla luciferase control activity.

Results {#s0050}
=======

Inactivation of *β-catenin* in the dental mesenchyme affects incisor number {#s0055}
---------------------------------------------------------------------------

Previous data have established important roles for Wnt/β-catenin signaling for tooth development in the dental epithelium and recently in the mesenchyme. In various Wnt-reporter mice such as Top-GAL, BAT-GAL and *Axin2*-lacZ mice reporter activity in the dental mesenchyme can first be detected in the incisor regions from E11.5 onwards (Supplementary Fig. 1A--C and data not shown), suggesting a potential role for Wnt/β-catenin signaling in the dental mesenchyme for incisor development. In order to delete β-catenin activity in the dental mesenchyme we used the *Prx1*-Cre line ([@bb0155]). Using the Z/AP reporter mouse we could show that *Prx1*-Cre has mosaic activity in the mesenchyme of the mandibular incisor region from E11.5 onwards, while we could not detect any activity in the molar region (Supplementary Fig. 1D--H). Skeletal preparations of P0 *β-catenin* conditional mutant heads derived from intercrosses of *Prx1*-Cre;*β-cat*^*+/lacZ*^ males with homozygous *β-cat*^*fl/fl*^ females revealed in 5/12 *β-cat*^*∆Prx/lacZ*^ mutants the presence of two incisors on one side of the mandible only, while 2/12 mutants had two incisors on both sides. In contrast, wild-type embryos have only one incisor per mandibular half ([Fig. 1](#f0005){ref-type="fig"}A, and data not shown). H&E staining of sagittal and frontal sections of E18.5 *β-cat*^*∆Prx/lacZ*^ heads showed that the two incisors developed on top of each other ([Fig. 1](#f0005){ref-type="fig"}B, C). In addition, we noticed that the incisors in the mutants were shorter and showed altered ameloblast distribution ([Fig. 1](#f0005){ref-type="fig"}B and Supplementary Fig. 2). The observed shortening of the incisors is probably a secondary event and due to the presence of ectopic cartilage (asterisks in [Fig. 1](#f0005){ref-type="fig"}B, C). Formation of ectopic cartilage primarily occurred within the bone region and is probably due to a differentiation of chondrocytes instead of osteoblasts as previously reported in the limbs and skulls of conditional β-catenin mutants ([@bb0055; @bb0075]). The first clear morphological differences with regard to incisor development were observed as early as E13.5 (*n* = 3/6, [Fig. 1](#f0005){ref-type="fig"}D), while at E12.5 and E11.5 the incisors in mutants resembled those of wild-types (*n* = 3, [Fig. 1](#f0005){ref-type="fig"}E, and data not shown).

To further support the *in vivo* observations by an independent experimental approach we performed the following *in vitro* experiments. Single incisor anlagen were dissected from E12.5 *β-cat*^fl/fl^ mandibles and the dental mesenchyme was infected with adenovirally expressed *Cre*-recombinase to inactivate the *β-catenin* gene. Subsequently, the partially infected, partly mutant mesenchyme was recombined with wild type E12.5 dental epithelium, cultured for 24 h, and then implanted into the kidney capsule and grown there for 3 weeks. The frequency in recovering incisors and not only bone in those *in vitro* experiments was very low, with incisors present in only 8/35 adeno-Cre treated and 5/34 adeno-GFP treated control recombinant explants. In 1/8 adeno-Cre treated cases two incisors instead of one developed from a single incisor anlage (Supplementary Fig. 2M). This was not observed in the control tissue recombination experiments (infected with adeno-GFP; *n* = 5). Thus, the preliminary result from the *in vitro* recombination experiment supports the *in vivo* genetic analysis ([Fig. 1](#f0005){ref-type="fig"}A--D)*,* suggesting that local inactivation of *β-catenin* in the mesenchyme of the incisor anlage can lead to incisor duplication.

The loss of *β-catenin* alters *Shh* and *Bmp4* expression {#s0060}
----------------------------------------------------------

In order to identify the underlying molecular alterations we examined the expression of genes critical for tooth development such as *Shh*, *Msx1*, *Msx2*, *Pax9*, *Axin2*, *Fgf3*, *Fgf8*, *Fgf9*, *Fgf10*, and *Bmp2*, *Bmp4*, and *Bmp7* in the incisor region. At E11.5, the distribution and levels of *Fgf8* (*n* = 6), *Shh* (*n* = 5), *Fgf9* (*n* = 5) and *Fgf10* (*n* = 6) were not altered in the dental epithelium ([Fig. 2](#f0010){ref-type="fig"}A, B, and data not shown). The expression of mesenchymal genes such as *Msx1* (*n* = 5), *Msx2* (*n* = 6) and *Pax9* (*n* = 6) expression domain were not noticeably altered ([Fig. 2](#f0010){ref-type="fig"}C, D, and data not shown). This was confirmed for *Msx1* by section in situ analysis (data not shown). In contrast, *Bmp4* expression appeared patchy in the mutant mesenchyme in comparison to the homogenous expression in wild-types (*n* = 5/5, [Fig. 2](#f0010){ref-type="fig"}E). A similar patchy down-regulation was observed for the bona fide Wnt target gene *Axin2* (*n* = 3/4; [Fig. 2](#f0010){ref-type="fig"}F) and confirmed on sections by in situ hybridization (Supplementary Fig. 3B). The expression of other BMP family members, such as *Bmp2* and *Bmp7,* which were expressed in the mandible at E11.5 in the epithelium or in the epithelium and mesenchyme, respectively, were not altered in *β-catenin* mutants (Supplementary Fig. 3C--E). Quantification of total transcript levels in the mandibular region by real-time PCR showed a significant reduction of *Bmp4*, but not *Bmp7* expression (Supplementary Fig. 3F). From E12.5 onwards, the *Shh* expression domain appeared to be split into two small dots either bi- (*n* = 4/11) or unilaterally (*n* = 7/11) ([Fig. 2](#f0010){ref-type="fig"}G). The split in the *Shh* expression domain was confirmed by section *in situ* hybridization using frontal sections (*n* = 3/4, [Fig. 3](#f0015){ref-type="fig"}A, C). Hybridization of alternating sections to *Bmp4* or using two-color in situ detection showed that *Bmp4* is highly expressed in the mesenchyme directly underneath the *Shh* expression domain in wild-type controls ([Fig. 3](#f0015){ref-type="fig"}B, C, E). In mutants with a split *Shh* expression domain, two high level *Bmp4* expression domains are apparent in conjunction with a slight reduction of the overall *Bmp4* levels in the mandibular mesenchyme ([Fig. 3](#f0015){ref-type="fig"}B, C). Consistent with the whole mount in situ observations *Msx1* was still expressed throughout the dental mandibular mesenchyme, including the region where *Bmp4* was down-regulated (*n* = 2, [Fig. 3](#f0015){ref-type="fig"}D). We used double fluorescent section *in situ* hybridization to establish that *Bmp4* expression was specifically lost from regions deficient in *β-catenin* ([Fig. 3](#f0015){ref-type="fig"}E--G). In contrast to what we had observed in the Z/AP reporter staining, recombination for the *β-catenin* locus was more restricted at E12.5, resulting in a patchy, mosaic loss of *β-catenin* expression ([Fig. 3](#f0015){ref-type="fig"}F). The epithelial and mesenchymal cells surrounding the split *Shh* expression domains were proliferating normally and no increase in cellular apoptosis was observed (Supplementary Fig. 4). Expression of *Fgf10* was not altered at E13.5, while *Fgf3* expression was reduced (data not shown). Thus the first change that we are able to detect in mutants lacking *β-catenin* in a mosaic manner in their mesenchyme was a mosaic down-regulation in expressions of *Bmp4* and the bona fide Wnt/β-catenin target gene *Axin2* in the dental mesenchyme.

Alteration of BMP4 activity and expression affect *Shh* expression in the incisor {#s0065}
---------------------------------------------------------------------------------

As down-regulation of *Bmp4* expression in the dental mesenchyme of *β-cat*^*∆Prx/lacZ*^ embryos seems to precede the alterations in *Shh* expression, we asked whether there is a causal connection. Therefore, BMP activity was inhibited in *in vitro* explant-cultures using the BMP antagonist NOGGIN. NOGGIN-soaked beads were implanted near the incisor region of wild-type E11.5 mandibles, which were then cultured for 48 h. In about 50% of all NOGGIN treated cultures, the *Shh* expression domain was split (8/15), associated with a down-regulation of *Shh* in 4/8 cases showing the split expression ([Fig. 4](#f0020){ref-type="fig"}A, and data not shown). Next we asked whether genetic inactivation of *Bmp4* in dental mesenchyme would alter *Shh* expression. This was achieved by crossing females homozygous for the hypomorphic *Bmp4*^*hf*^ allele with males double-heterozygous for the *Bmp4*^*∆lacZ*^ null allele and the *Prx1*Cre transgene ([@bb0010]). At E12.5 (*n* = 2) *Shh* was completely absent from the incisor and molar regions of mandibles of *Bmp4* deficient (*Bmp4*^*hf∆Prx/∆lacZ*^) embryos, while its expression was unaffected in littermate controls ([Fig. 4](#f0020){ref-type="fig"}B). In contrast, *Shh* expression was only reduced and the two domains fused at the midline in the *Bmp4* (*Bmp4*^*hf∆Prx/∆lacZ*^*)* deficient embryonic mandibles at E11.5 (*n* = 2; [Fig. 4](#f0020){ref-type="fig"}C). When we examined the efficiency of the *Bmp4* deletion in *Bmp4*^*hf∆Prx/∆lacZ*^ mandibles at E11.5 using a *Bmp4* probe detecting the deleted exon 4, it became apparent that *Bmp4* expression was in general severely reduced but not completely lost (*n* = 2; [Fig. 4](#f0020){ref-type="fig"}D). Interestingly, when we looked at the expression of *Msx1* in the *Bmp4* mutants at E11.5, we did not observe a decrease in the expression levels (*n* = 2/2; [Fig. 4](#f0020){ref-type="fig"}E). As expected, *Bmp4* expression was also reduced in the mandibles of *Bmp4*^∆lacZ/hf^ embryos (*n* = 2/3), but *Shh* expression was not lost at E12.5 (*n* = 1; data not shown). At E14.5, either no (*n* = 1/3) or only weak *Shh* expression in one or two tiny spots was detected at the tip of *Bmp4*^*hf∆Prx/∆lacZ*^ mandibles (*n* = 2/3) ([Fig. 4](#f0020){ref-type="fig"}E). In contrast to the local reduction of *Bmp4* expression in *β-cat*^*∆Prx/lacZ*^ mandibles ([Fig. 3](#f0015){ref-type="fig"}C) the almost complete loss in *Bmp4*^*hf∆Prx/∆lacZ*^ embryos provides a feasible explanation for why *Shh* expression is lost in *Bmp4*^*hf∆Prx/∆lacZ*^ rather than being split. In addition, we examined *Shh* expression in *Bmp4*^*∆Prx/∆GL*^ mutants, in which a none-hypomorphic conditional allele of *Bmp4* ([@bb0025]) had been deleted using the *Prx1-*Cre in the presence of a germ-line deleted *Bmp4*^*∆GL/+*^ allele. However, using this *Bmp4* loss-of-function allele, only minimal changes in *Bmp4* expression (*n* = 3/4) and no significant changes in *Shh* expression (*n* = 3) were observed in the mandibles (Supplementary Fig. 5). In contrast to the mandibles, mesenchymal *Bmp4* expression is completely lost in the limb, but again we did not observe a loss of *Msx1* expression (*n* = 2; Supplementary Fig. 5C, D). Taken together, this genetic analysis indicates that BMP4 activity is likely to be required for maintenance but not initiation of epithelial *Shh* expression. Furthermore, our genetic data suggest that *Msx1* is not a Bmp4-dependent gene.

*Bmp4* is a direct target of a β-catenin--Tcf1--Lef1 complex {#s0070}
------------------------------------------------------------

Since *Msx1*, which has been shown previously to be required for *Bmp4* expression in the dental mesenchyme ([@bb0030]), was not affected by the loss of β-catenin activity, we determined whether *Bmp4* is a transcriptional target of Wnt/β-catenin signaling in the dental mesenchyme. *In silico* analysis using the transfac database revealed that a 4.8 kb upstream region of the *Bmp4* locus encodes approximately 33 putative TCF/LEF binding sites ([Fig. 5](#f0025){ref-type="fig"}A). Some of those binding sites are conserved between rat and mouse or rat, mouse and human based on a CLUSTALW analysis (indicated by one or two asterisks respectively, see [Fig. 5](#f0025){ref-type="fig"}A). *Bmp4*-reporter constructs encoding either the 4.8 kb up stream region or a shorter 3 kb region (containing approximately 21 potential TCF/LEF binding sites) were transactivated in luciferase assays upon co-transfection of expression plasmids for both *Lef1* and *β-catenin*, *Tcf1* and *β-catenin* or an expression plasmid encoding a TCF1-β-catenin fusion protein ([Fig. 5](#f0025){ref-type="fig"}B, and data not shown). Next, we determined whether *Bmp4* expression is altered in the dental mesenchyme of *Tcf1* and/or *Lef1* mutant mandibles at E11.5. However, no significant difference in *Bmp4* expression was observed in the incisor regions of *Lef1*^−/−^ or *Tcf1*^−*/*−^ embryos in comparison to controls at E11.5 (*n* = 3; [Fig. 5](#f0025){ref-type="fig"}C). In compound *Tcf1*;*Lef1* mutant embryos (*Tcf1*^−*/*−^*;Lef1*^*+/*−^ *n* = 5/6 and *Tcf1*^*+/*−^*;Lef1*^−*/*−^ *n* = 4/4) the overall expression of *Bmp4* was slightly reduced ([Fig. 5](#f0025){ref-type="fig"}D), while *Bmp4* expression was completely lost in *Tcf1*^−*/*−^*:Lef1*^−*/*−^ mutant embryos at E11.5 (*n* = 2/2; [Fig. 5](#f0025){ref-type="fig"}D). Given the severity of the embryonic defects and the developmental retardation of the *Tcf1/Lef1* double mutant embryos at E11.5 it is possible that the loss of *Bmp4* is due to secondary effects. However, when we analyzed E9.5 double mutant embryos, which are fairly similar to wild-type and single mutant embryos, we could already at this stage observe a reduction in the *Bmp4* expression in the mandibles of *Tcf1*^−*/*−^*:Lef1*^−*/*−^ compared to littermate *Tcf1*^−*/*−^*;Lef1*^*+/+*^ mutant embryos ([Fig. 5](#f0025){ref-type="fig"}E). At this stage a rudimentary forelimb was still present, which also showed reduced *Bmp4* expression (data not shown).

Although all four Tcf/Lef family members are expressed in the dental mesenchyme at E11.5 (Supplementary Fig. 6), the almost complete absence of *Bmp4* expression in *Tcf1/Lef1* double mutants would suggest that *Tcf1* and *Lef1* are the primary transcriptional co-factors, which in a complex with β-catenin, regulate *Bmp4* expression in the dental and possibly also in the limb mesenchyme.

Discussion {#s0075}
==========

Mesenchymal β-catenin activity regulating *Bmp4* is required for incisor development {#s0080}
------------------------------------------------------------------------------------

Various ectodermal appendages including teeth depend on canonical Wnt/β-catenin signaling ([@bb0175]). Until recently it was thought that this pathway is primarily required in the dental epithelium during tooth development. This notion was supported by the finding that TCF/LEF reporters seem not to be active in the molar mesenchyme ([@bb0140]). However, here we show that there is activity of various Wnt-reporter mice in the early incisor mesenchyme of the lower jaw. Recently, the analysis of a conditional *β-catenin* mutant by Chen and colleagues established that β-catenin is required in the dental mesenchyme during tooth development ([@bb0035]). Their study showed that following *β-catenin* inactivation, molar and incisor formation arrests at bud stage but the underlying molecular alterations resulting in this arrest remained unknown. In contrast we show that sporadic deletion of *β-catenin* in the incisor mesenchyme of the lower jaw using the *Prx1-Cre* recombinase transgene resulted in a double-incisor phenotype in about 50% of all mutant embryos. Our molecular analysis revealed that in parallel to the onset of *Prx1-Cre* activity, gene expressions were altered starting around E11.5. In particular, mesenchymal *Bmp4* and *Axin2* expressions were down-regulated in a patchy manner as a likely first molecular alteration in the mosaic *β-catenin* deficient mesenchyme. The changes in *Bmp4* expression appear to occur in an *Msx1*-independent manner and cell-autonomously, coinciding with the local loss of *β-catenin.* These cell-autonomous changes together with the *Bmp4* promoter analysis suggest that *Bmp4* might be a direct target of β-catenin/TCF/LEF mediated transcription in the dental mesenchyme. β-catenin has been shown to regulate *Bmp4* in other tissues such as cancer cells, lung, limb and eye ([@bb0080; @bb0110; @bb0225; @bb0280]). Consistent with our *in vitro* data, it has been shown previously that β-catenin can activate and bind to a 2.4-kb *Bmp4* promoter region *in vitro* ([@bb0225; @bb0230]). Based on the results from transgenic promoter studies this region is, however, not sufficient to drive expression in the primordial tooth anlage ([@bb0060]). Thus the more upstream located Tcf/Lef binding sites might be the ones, which regulate Bmp4 expression in the early tooth anlage. This needs to be demonstrated in the future by *in vivo* ChIP experiments and transgenic promoter studies. Nevertheless given that *Bmp4* expression was reduced in mandibles of compound *Tcf1/Lef1* mutants and lost in mandibles of double mutants supports our model that β-catenin, together with Tcf1 and Lef1, which are both expressed in the dental mesenchyme at E11.5, directly regulates *Bmp4* expression in the dental mesenchyme ([Fig. 6](#f0030){ref-type="fig"}). So similar to what has been reported in the limb, *Tcf1* and *Lef1* seem to act redundantly in the mandibular mesenchyme ([@bb0065]). Furthermore, our data establish that *Tcf1* plays a functional, albeit redundant role in tooth development. Interestingly, Bmp4 has been shown to regulate *Lef1* expression in the dental mesenchyme ([@bb0030]), thus establishing a positive feed-back loop (see model [Fig. 6](#f0030){ref-type="fig"}). In addition to the *Bmp4* down-regulation, *Shh* expression in the overlying dental epithelium was altered in the conditional *β-catenin* mutant mandibles. *Bmp4* has been previously implicated in regulating *Shh* and *Bmp2* expression in the dental epithelium of the molars based on the analysis of *Msx1* deficient mouse embryos and *in vitro* explant studies ([@bb0270]). Alteration of BMP activity in mandibular explants by NOGGIN-bead implantation affects *Shh* expression in a manner similar to loss of mesenchymal β-catenin activity, which supports the notion that BMP activity is required to maintain *Shh* expression in the incisor region. In addition, it has been recently shown that treatment of incisor explants with NOGGIN resulted in splitting of the *Shh* expression domain and the development of to up to three incisors, dependent on the NOGGIN concentration ([@bb0185]). This further supports the idea that alteration of BMP-signaling influences *Shh* expression and incisor number. Importantly, genetic inactivation of *Bmp4* in the dental mesenchyme establishes that it is the mesenchymal activity of BMP4, which is indeed required for the maintenance of *Shh* in the dental epithelium of molars and incisors*,* but not for its induction. Therefore, we hypothesize that the *Shh* expression domain splits only in those cases where the regions lacking *Bmp4* expression in the mesenchyme were substantial and directly abutting the overlying epithelium ([Fig. 6](#f0030){ref-type="fig"}). The study by [@bb0270] reported that *Bmp4* might also inhibit *Shh* expression at least at high concentrations *in vitro*. Thus, BMP4 in combination with other factors might regulate *Shh* expression differentially over time in a concentration-dependent manner, which might explain why residual *Shh* expression was detected in 2 out of 3 *Bmp4* deficient embryos at E14.5. Alterations in the *Shh* expression domain might ultimately affect the invagination of dental epithelium, as loss of *Shh* at the early bud stage and inhibition of *Shh* activity at the epithelial thickening stage is known to alter growth and morphogenesis of teeth ([@bb0040; @bb0050]). Furthermore, ectopic application of SHH protein to oral epithelium induces invagination of non-dental epithelium ([@bb0070]). Thus the generation of a second *Shh* expressing center within the dental epithelium might be one of the key steps triggering the second invagination that causes the formation of a second incisor in *β-cat*^*∆Prx/lacZ*^ mutant embryos.

These phenotypic and molecular alterations were not observed in the previous genetic analysis by [@bb0035]. This might be due to differences in the onset of Cre-recombinase activity in the mandibular region as at least for the *Osr2-IresCre* no recombinase activity was reported prior to E14.5 in incisor regions ([@bb0125]). On the other hand the deletion efficiency might vary between the different Cre-lines. In particular, we have observed that deletion of *β-catenin* in different *β-cat*^*∆Prx/lacZ*^ mutant embryos was patchy and variable. This observation probably also explains why the penetrance of the double-incisor phenotype was not 100%. Similarly, only incomplete and patchy inactivation of β-catenin activity was achieved in the adenovirally infected mesenchymal explants, explaining probably why a double-incisor was only observed in one case.

Local alterations in the β-catenin/BMP4 circuits affect incisor number {#s0085}
----------------------------------------------------------------------

Although adult mice have only one upper and lower incisor, mouse embryos still show a more ancestral pattern with about six vestigial incisor placodes in the upper and three in the lower half of the developing jaw ([@bb0210]). The entire epithelial area, comprising all placodes, folds normally into the mesenchyme, but is thought to form only one incisor through an incorporation process potentially due to the failure to form inhibitory zones ([@bb0210]). These inhibitory zones might be regulated by reaction--diffusion interactions of growth inhibitors and activators similar to Turing-type mechanisms, but may have been lost or became suppressed during rodent evolution ([@bb0205; @bb0245]). Recently it has been shown that the mesenchyme surrounding the incisor tooth germ has the capability to restrict tooth induction ([@bb0180]). This repressive potential of the mesenchyme is in part mediated by ectodin, which is encoded by the *Sostdc1* gene ([@bb0180]). Ectodin, is related to Sclerostin and is known to modulate the Wnt-pathway and to potentially inhibit BMP-signaling ([@bb0095; @bb0130; @bb0135]). However, the timing and mode of supernumerary incisor formation in *Sostdc1* mutants is distinct from the duplications observed following *β-catenin* inactivation ([@bb0180; @bb0190]). Thus, we propose that in addition to the inhibitory potential of the dental mesenchyme there is also an activatory potential, which β-catenin and BMP4 are part of. This mesenchymal activatory pathway maintains the expression of critical factors in the dental epithelium, such as *Shh* and the *Bmp4* dependent cell cycle inhibitor p21 ([@bb0105]). A recent finding showed that treatment of mandibular explants with defined concentrations of the BMP antagonist Noggin leads to a destabilization of the large placode and the formation of two to three incisors ([@bb0185]). In agreement with these findings, our data suggest that local or non-uniform reduction of mesenchymal BMP activity due to the loss of β-catenin contributes to the formation of supernumerary incisors by splitting the signaling center, which results in the formation of two invaginations. Thus, a potential mechanism to alter incisor number would be to locally modulate β-catenin activity in the dental mesenchymal, thereby altering *Bmp4* expression and subsequently epithelial *Shh* expression. An alternative explanation, for the observed phenotype might be that reduced Wnt/BMP4 signaling somehow affects survival/revitalization of the posterior incisor placode, which normally regresses around E13.5. This explanation is in agreement with earlier findings by Zhang and colleagues, which showed that high levels of BMP4 inhibit *Shh* expression in the molar and incisor region ([@bb0270]). However, based on this alternative model one would have expected increased *Shh* expression upon reduction of BMP4 activity in the mesenchyme, which we did not observe.

Appendix A. Supplementary data
==============================
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![Deletion of *β-catenin* in the dental mesenchyme increases the number of incisors. (A) Skeletal preparation of WT and *β-cat*^*∆Prx/lacZ*^ newborn (P0) showing one half of a mandibular jaw. Note the double incisors at the distal tip (indicated by arrows) in the *β-cat*^*∆Prx/lacZ*^ mutant compared to the one incisor in the wild-type jaw. (B--D) H&E stained sagittal (B) and frontal (C) sections of E18.5 heads, and frontal sections of E13.5 heads (D), showing the presence of double incisors and the early invagination of a second incisor anlage in *β-cat*^*∆Prx/lacZ*^ mandibles. (E) Frontal sections of E12.5 heads, showing a similar appearance for the incisor anlage in *β-cat*^*∆Prx/lacZ*^ and wild-type mandibles. Asterisk in B and C indicates formation of ectopic cartilage in *β-cat*^*∆Prx/lacZ*^ mutants. White lines in (D, E) mark the boundaries between epithelium and mesenchyme.](gr1){#f0005}

![Alterations in gene expression in *β-cat*^*∆Prx/lacZ*^ mutant mandibles at early stages of tooth development. (A--F) In situ hybridization showing the expression of *Fgf8*, *Shh*, *Msx1*, *Pax9* and *Bmp4* at E11.5 and (G) *Shh* at E12.5 in wild-type and *β-cat*^*∆Prx/lacZ*^ mutant mandibles. No significant changes in the expression of *Fgf8* (A), *Shh* (B), *Msx1* (C), and *Pax9* (D) were observed in *β-cat*^*∆Prx/lacZ*^ mutant mandibles at E11.5. (E) Patchy expression of *Bmp4* in *β-cat*^*∆Prx/lacZ*^ mutant mandibles at E11.5. See also magnified region of the white-boxed area in the right corner. (F) Patchy expression of *Axin2* in *β-cat*^*∆Prx/lacZ*^ mutant mandibles at E11.5. See also magnified region of the white-boxed area in the right corner. (G) Split *Shh* expression domain in the incisor region of *β-cat*^*∆Prx/lacZ*^ mandibles; in this case on both sides (indicated by arrowheads).](gr2){#f0010}

![Correlation between alterations in mesenchymal *Bmp4* and epithelial *Shh* expression upon inactivation of mesenchymal *β-catenin*. (A--G) Frontal section showing incisor tooth buds at E12.5. (A, B) Alternating sections showing a split *Shh* expression domain on one side of the incisor region in the *β-cat*^*∆Prx/lacZ*^ mutant mandibles (A) and a similar split in epithelial *Bmp4* expression and overall reduction of its mesenchymal expression (B). (C) Two-color *in situ* hybridization for *Shh* (red) and *Bmp4* (blue) in mandibular incisor buds at E12.5; note the high level mesenchymal *Bmp4* expression domain directly abutting the epithelial *Shh* expression domain (red) in wild-types, which is split in two domains associated with a split *Shh* expression in the epithelium in the *β-cat*^*∆Prx/lacZ*^ mutant incisor bud region. (D) Adjacent section showing that *Msx1* expression in not down-regulated in the region lacking Bmp4. (E-G) Double fluorescent *in situ* hybridization for *Bmp4* (red) and *β-catenin* (green) in the incisor bud of wild-type and *β-cat*^*∆Prx/lacZ*^ at E12.5. Note that the loss-of *Bmp4* expression in the area underneath the invaginating epithelium (red arrows in E) corresponds to the regions in which *β-catenin* expression has been inactivated in the dental mesenchyme (green arrows in F). (G) Merged images of (E, F). Right panel: higher magnification images, showing the areas where *Bmp4* transcripts (red) are down-regulated (surrounded by the thin line; labeled 1, 2, 3 in the merged image) corresponding to areas showing deletion of *β-catenin* (green). Red lines in A and B, and white lines in E--G mark the boundary between epithelium and mesenchyme. Asterisks in the higher magnifications shown in the right panel mark holes in the tissue.](gr3){#f0015}

![Alterations in BMP4 activity affect *Shh* expression in the dental epithelium. (A) *In situ* detection of *Shh* expression in E11.5 mouse mandibular explants cultured for 48 h with BSA- (white) or NOGGIN- (blue) soaked beads. Note the split in the *Shh* expression domain on the side where the NOGGIN-soaked bead was implanted. The right panel shows a higher magnification of the incisor area (white box in the left panel). (B--E) *Shh* and *Bmp4* expression in mandibles of *Bmp4*^*hfΔPrx1/ΔlacZ*^ mice. (B) Loss of *Shh* in molar and incisor regions in *Bmp4*^*hfΔPrx1/ΔlacZ*^ deficient mandibles at E12.5. (C) Down-regulation of *Shh* in the presumptive incisor and molar regions in *Bmp4*^*hfΔPrx1/ΔlacZ*^ mandible at E11.5. Note that the expression domains are fused at the mid-line. (D) *Bmp4* expression, using an exon4 specific *in situ* hybridization probe, is almost completely lost in *Bmp4* mutant mandibles at E11.5. (E) *Msx1* expression pattern in E11.5 wild-type and *Bmp4* mutant mandibles. Note *Msx1* expression is not down-regulated in the *Bmp4* mutant mandibles. (F) Presence of tiny *Shh* expression domains in the incisor and molar regions of *Bmp4* mutant mandibles at E14.5.](gr4){#f0020}

![*In vitro* and *in vivo* regulation of *Bmp4* expression by β-catenin in combination with Tcf/Lef family members**.** (A) Schematic overview over the −4.8 kb mouse *Bmp4* promoter region indicates the location of putative Tcf/Lef binding sites (light blue). Sites conserved between human, rat and mouse are indicated by two red asterisks, those conserved between rat and mouse by one red asterisk. (B) Luciferase assay using the -3.0 kb *Bmp4* promoter region in response to control, increasing levels of *Lef1* and *β-catenin*, *Tcf1* and *β-catenin* or a TCF1*-β-catenin* fusion expression constructs. Error bars represent the standard deviation (s.d.). (C) *Bmp4* expression in mandibles of wild-type, *Tcf1* and *Lef1* single mutant embryos at E11.5. No obvious difference in *Bmp4* expression was observed in *Tcf1*^−*/*−^ and *Lef1*^−*/*−^ single mutants. (D) *Bmp4* expression in mandibles of *Tcf1;Lef1* compound and double mutant embryos at E11.5. *Bmp4* expression was reduced in the compound mutants and completely lost in embryos lacking both *Tcf1* and *Lef1*. Higher magnifications of the boxed areas are shown in the upper right corners. (E) *Bmp4* expression in the mandibles (Md) of *Tcf1*^−*/*−^*;Lef1*^+/+^ and *Tcf1*^−*/*−^*;Lef1*^−*/*−^ mutant embryos (frontal view, upper row; lateral view, lower row) at E9.5. Arrowheads point at the *Bmp4* expression domain.](gr5){#f0025}

![Model of the β-catenin/BMP4 circuit maintaining *Shh* expression in wild-type and *β-catenin* mutant incisor regions. (A) β-catenin in a transcriptional complex with Tcf1 and Lef1 activates the expression of Bmp4 (indicated by the light and dark orange domains) independently of Msx1 in the dental mesenchyme at stage E11.5. Mesenchymal BMP4 activity maintains continuous expression of *Shh* (indicated by the red domain) in the overlying dental epithelium and regulates *Lef1* expression in the dental mesenchyme. (B) Local loss of β-catenin in the region of high *Bmp4* expression (indicated in dark orange) results in a BMP4 deficient region, which fails to maintain *Shh* expression in the overlying dental epithelium, generating a gap within the *Shh* expressing placode. The split *Shh* expression domains will invaginate independently giving rise to two incisors in the adult.](gr6){#f0030}
